WHO-UMC-HSA Inter-Regional Pharmacovigilance Training workshop

  • 15 August, 2018 to 17 August, 2018
  • 9:00am - 6:00pm


Expert pharmacovigilance trainers from the World Health Organisation (WHO), the Uppsala Monitoring Centre (UMC), and the Health Sciences Authority (HSA) of Singapore, will share with participants their expertise and experience over a 3-day workshop, jointly organised with the WHO, UMC, HSA, and CoRE, as part of a continuation of efforts to enhance pharmacovigilance capabilities in the ASEAN region. Given this year’s underlying theme of “Partnerships to Protect Public Health”, we welcome participation from non-regulators, such as people from the industry and non-government organisations (NGOs).

Graduate Certificate in Pharmaceutical Regulation Registration Form

  • Graduate Certificate Registration

Thank you for your interest in our Graduate Certificate Programme. Please click below to sign up for GMS5104:Biotherapeutics and Biosimilars Course.

CoRE Symposium 2018: New Visions for Advancing Regulatory Science and Public Health

  • 3 October, 2018
  • 2:00pm - 5:00pm

Adapting patient care to an environment of evolving medical knowledge and innovative product development demands a sharp ability to forecast the upcoming needs of the future. Regulatory systems are expected to support innovation and facilitate patients’ access to new effective treatments. The increasing involvement of patients in shaping health policies and decision-making indicates the progressive movement towards patient-centric care. Hear from the speakers the insights on how various stakeholders are being positioned to accommodate these new demands, as they share from their experiences and global perspectives in envisioning optimal approaches for advancing public health. 

APEC RHSC CoE Pilot Workshop - Biotherapeutics and Biosimilars

  • 29 October, 2018 to 30 October, 2018
  • 8:00am - 6:00pm

Biotherapeutics, or medicinal products manufactured using living cells or tissues, are the trending developments from leading pharmaceuticals in the treatment of conditions related to oncology and immunology among others. The exponential progression in science and medical practices necessitates all involved or interested in this field to keep current with the developments. In particular, the increasing production of biosimilars, or generics of biotherapeutics, demands the attention of regulatory professionals. In the context of the complex scientific knowledge and the evolving understanding of good practices in regulating these products, this APEC Regulatory Harmonisation Steering Committee pilot Workshop, in conjunction with the APEC Harmonisation Centre, aims to provide the necessary foundations in understanding the regulatory controls for these innovations, including aspects of quality, non-clinical and clinical considerations.